Brief: NKGen Biotech Says Co And Seller Entered Into Amendment To Forward Purchase Agreement
27/12/2023 21:17
Dec 27 (Reuters) - NKGen Biotech Inc NKGN.O :
* NKGEN BIOTECH INC: ON DEC 26, CO AND SELLER ENTERED INTO
AN
AMENDMENT TO FORWARD PURCHASE AGREEMENT, DATED AS OF SEPT 22,
2023
* NKGEN BIOTECH INC: PURSUANT TO AMENDMENT, CO AND SELLER
AGREED
TO LOWER RESET PRICE
* NKGEN BIOTECH INC: PURSUANT TO AMENDMENT, CO AND SELLER
AGREED
TO INCREASE SHARE CONSIDERATION SHARES BY 200,000 SHARES OF
COMPANY'S COMMON STOCK
Further company coverage: NKGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkgen Biotech
See all newsBrief: Nkgen Biotech Expands Clinical Trial Site Network For Alzheimer’S Disease Program Across US
Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
Brief: Nkgen Biotech Announces International And U.S. Expansion Of Phase 1/2A Troculeucel Alzheimer’S Trial
Brief: Nkgen Biotech Announces Administration Of First Dose Of Troculeucel To Stroke Patient Under FDA-Cleared Compassionate Use Program
Brief: NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program